Approaching the 12th consecutive year, the goal for BioTrinity is simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future. The 2018 theme for BioTrinity is ‘Next Generation Healthcare’ which will be explored via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘Fintech and the Future of the Investment Industry’.
BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors. For more information on OBN visit their website.
Martin Gouldstone will be speaking on a panel about the ‘Pros and Cons of IPO’ at Biotrinity (11.10 – 11.50 on Wednesday 25 April) – see the agenda here.
Kunal Kadiwar, Petra Milkovic and Tim Sturgeon will be attending the conference.
To arrange a meeting with the Results Healthcare team at BioTrinity please click contact us below.